Interactions between CD47 and thrombospondin reduce inflammation

Journal of Immunology

Volumn 178, Issue 9, 2007, Pages 5930-5939

  Lamy, Laurence ^a   Foussat, Arnaud ^a   Brown, Eric J ^b   Bornstein, Paul ^c   Ticchioni, Michel ^a   Bernard, Alain ^a,d  

^a UNIVERSITY HOSPITAL OF NICE   (France)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD47 ANTIGEN; E1B PROTEIN; OXAZOLONE; PROTEASOME; PROTEIN BCL 2; PROTEIN BNIP3; THROMBOSPONDIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FEMALE; INFLAMMATION; KNOCKOUT MOUSE; LYMPHOCYTE COUNT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; WILD TYPE;

EID: 34247608723     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.9.5930     Document Type: Article

References (60)

1. Smith, C. A., T. Farrah, and R. G. Goodwin. 1994. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76: 959-962.
2. Bernard, G., J. P. Breittmayer, M. de Matteis, P. Trampont, P. Hofman, A. Senik, and A. Bernard. 1997. Apoptosis of immature thymocytes mediated by E2/CD99. J. Immunol. 158: 2543-2550.
3. + T cells. Proc. Natl. Acad. Sci. USA 95: 12556-12561.
4. Deas, O., C. Dumont, M. MacFarlane, M. Rouleau, C. Hebib, F. Harper, F. Hirsch, B. Charpentier, G. M. Cohen, and A. Senik. 1998. Caspase-independent cell death induced by anti-CD2 or staurosporine in activated human peripheral T lymphocytes. J. Immunol. 161: 3375-3383.
5. Pettersen, R. D., K. Hestdal, M. K. Olafsen, S. O. Lie, and F. P. Lindberg. 1999. CD47 signals T cell death. J. Immunol. 162: 7031-7040.
6. 2-terminal kinase activity: a novel apoptotic pathway distinct from Fas-induced apoptosis. J. Cell Biol. 139: 1523-1531.
7. Mateo, V., L. Lagneaux, D. Bron, G. Biron, M. Armant, G. Delespesse, and M. Sarfati. 1999. CD47 ligation induces caspase-independent cell death in chronic lymphocytic leukemia. Nat. Med. 5: 1277-1284.
8. Ticchioni, M., M. Deckert, F. Mary, G. Bernard, E. J. Brown, and A. Bernard. 1997. Integrin-associated protein (CD47) is a comitogenic molecule on CD3-activated human T cells. J. Immunol. 158: 677-684.
9. Reinhold, M. I., J. M. Green, F. P. Lindberg, M. Ticchioni, and E. J. Brown. 1999. Cell spreading distinguishes the mechanism of augmentation of T cell activation by integrin-associated protein/CD47 and CD28. Int. Immunol. 11: 707-718.
10. Reinhold, M. I., F. P. Lindberg, G. J. Kersh, P. M. Allen, and E. J. Brown. 1997. Costimulation of T cell activation by integrin-associated protein (CD47) is an adhesion-dependent, CD28-independent signaling pathway. J. Exp. Med. 185: 1-11.
11. Waclavicek, M., O. Majdic, T. Stulnig, M. Berger, T. Baumruker, W. Knapp, and W. F. Pickl. 1997. T cell stimulation via CD47: agonistic and antagonistic effects of CD47 monoclonal antibody 1/1A4. J. Immunol. 159: 5345-5354.
12. Avice, M. N., M. Rubio, M. Sergerie, G. Delespesse, and M. Sarfati. 2000. CD47 ligation selectively inhibits the development of human naive T cells into Th1 effectors. J. Immunol. 165: 4624-4631.
13. - T cells in response to inflammation. J. Immunol. 177: 3534-3541.
14. Manna, P. P., J. Dimitry, P. A. Oldenborg, and W. A. Frazier. 2005. CD47 augments Fas/CD95-mediated apoptosis. J. Biol. Chem. 280: 29637-29644.
15. Vernon-Wilson, E. F., W. J. Kee, A. C. Willis, A. N. Barclay, D. L. Simmons, and M. H. Brown. 2000. CD47 is a ligand for rat macrophage membrane signal regulatory protein SIRP (OX41) and human SIRPα 1. Eur. J. Immunol. 30: 2130-2137.
16. Brooke, G., J. D. Holbrook, M. H. Brown, and A. N. Barclay. 2004. Human lymphocytes interact directly with CD47 through a novel member of the signal regulatory protein (SIRP) family. J. Immunol. 173: 256-25702.
17. Piccio, L., W. Vermi, K. S. Boles, A. Fuchs, C. A. Strader, F. Facchetti, M. Cella, and M. Colonna. 2005. Adhesion of human T cells to antigen-presenting cells through SIRPβ2-CD47 interaction costimulates T-cell proliferation. Blood 105: 2421-2427.
18. Freyberg, M. A., D. Kaiser, R. Graf, J. Buttenbender, and P. Friedl. 2001. Proatherogenic flow conditions initiate endothelial apoptosis via thrombospondin-1 and the integrin-associated protein. Biochem. Biophys. Res. Commun. 286: 141-149.
19. Freyberg, M. A., D. Kaiser, R. Graf, P. Vischer, and P. Friedl. 2000. Integrin-associated protein and thrombospondin-1 as endothelial mechanosensitive death mediators. Biochem. Biophys. Res. Commun. 271: 584-588.
20. Graf, R., M. Freyberg, D. Kaiser, and P. Friedl. 2002. Mechanosensitive induction of apoptosis in fibroblasts is regulated by thrombospondin-1 and integrin associated protein (CD47). Apoptosis 7: 493-498.
21. Johansson, U., K. Higginbottom, and M. Londei. 2004. CD47 ligation induces a rapid caspase-independent apoptosis-like cell death in human monocytes and dendritic cells. Scand. J. Immunol. 59: 40-49.
22. Lamy, L., M. Ticchioni, A. K. Rouquette-Jazdanian, M. Samson, M. Deckert, A. H. Greenberg, and A. Bernard. 2003. CD47 and the 19 kDa interacting protein-3 (BNIP3) in T cell apoptosis. J. Biol. Chem. 278: 23915-23921.
23. Bornstein, P. 1995. Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1. J. Cell Biol. 130: 503-506.
24. Chen, F. H., A. O. Thomas, J. T. Hecht, M. B. Goldring, and J. Lawler. 2005. Cartilage oligomeric matrix protein/thrombospondin 5 supports chondrocyte attachment through interaction with integrins. J. Biol. Chem. 280: 32655-32661.
25. Hankenson, K. D., S. G. Hormuzdi, J. A. Meganck, and P. Bornstein. 2005. Mice with a disruption of the thrombospondin 3 gene differ in geometric and biomechanical properties of bone and have accelerated development of the femoral head. Mol. Cell. Biol. 25: 5599-5606.
26. Legrand, C., V. Dubernard, S. Rabhi-Sabile, and V. Morandi da Silva. 1997. Functional and clinical significance of thrombospondin. Platelets 8: 211-224.
27. Lange-Asschenfeldt, B., W. Weninger, P. Velasco, T. R. Kyriakides, U. H. von Andrian, P. Bornstein, and M. Detmar. 2002. Increased and prolonged inflammation and angiogenesis in delayed-type hypersensitivity reactions elicited in the skin of thrombospondin-2-deficient mice. Blood 99: 538-545.
28. Ray, R., G. Chen, C. Vande Velde, J. Cizeau, J. H. Park, J. C. Reed, R. D. Gietz, and A. H. Greenberg. 2000. BNIP3 heterodimerizes with Bcl-2/Bcl-X(L) and induces cell death independent of a Bcl-2 homology 3 (BH3) domain at both mitochondrial and nonmitochondrial sites. J. Biol. Chem. 275: 143-14489.
29. Yasuda, M., P. Theodorakis, T. Subramanian, and G. Chinnadurai. 1998. Adenovirus E1B-19K/BCL-2 interacting protein BNIP3 contains a BH3 domain and a mitochondrial targeting sequence. J. Biol. Chem. 273: 12415-12421.
30. Chen, G., R. Ray, D. Dubik, L. Shi, J. Cizeau, R. C. Bleackley, S. Saxena, R. D. Gietz, and A. H. Greenberg. 1997. The E1B 19K/Bcl-2-binding protein Nip3 is a dimeric mitochondrial protein that activates apoptosis. J. Exp. Med. 186: 1975-1983.
31. Bruick, R. K. 2000. Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc. Natl. Acad. Sci. USA 97: 9082-9087.
32. Guo, K., G. Searfoss, D. Krolikowski, M. Pagnoni, C. Franks, K. Clark, K. T. Yu, M. Jaye, and Y. Ivashchenko. 2001. Hypoxia induces the expression of the proapoptotic gene BNIP3. Cell Death Differ. 8: 367-376.
33. Wan, J., D. Martinvalet, X. Ji, C. Lois, S. M. Kaech, U. H. Von Andrian, J. Lieberman, R. Ahmed, and N. Manjunath. 2003. The Bcl-2 family pro-apoptotic molecule, BNIP3 regulates activation-induced cell death of effector cytotoxic T lymphocytes. Immunology 110: 10-17.
34. Vande Velde, C., J. Cizeau, D. Dubik, J. Alimonti, T. Brown, S. Israels, R. Hakem, and A. H. Greenberg. 2000. BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore. Mol. Cell. Biol. 20: 5454-5468.
35. + T cell-mediated contact hypersensitivity. J. Exp. Med. 189: 779-786.
36. + T cells. J. Immunol. 164: 2515-2522.
37. Lindberg, F. P., D. C. Bullard, T. E. Caver, H. D. Gresham, A. L. Beaudet, and E. J. Brown. 1996. Decreased resistance to bacterial infection and granulocyte defects in IAP-deficient mice. Science 274: 795-798.
38. Kyriakides, T. R., Y. H. Zhu, L. T. Smith, S. D. Bain, Z. Yang, M. T. Lin, K. G. Danielson, R. V. Iozzo, M. LaMarca, C. E. McKinney, et al. 1998. Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis. J. Cell Biol. 140: 419-430.
39. Agah, A., T. R. Kyriakides, J. Lawler, and P. Bornstein. 2002. The lack of thrombospondin-1 (TSP1) dictates the course of wound healing in double-TSP1/TSP2-null mice. Am. J. Pathol. 161: 831-839.
40. Gad, S. C., B. J. Dunn, D. W. Dobbs, C. Reilly, and R. D. Walsh. 1986. Development and validation of an alternative dermal sensitization test: the mouse ear swelling test (MEST). Toxicol. Appl. Pharmacol. 84: 93-114.
41. Wakkach, A., N. Fournier, V. Brun, J. P. Breittmayer, F. Cottrez, and H. Groux. 2003. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 18: 605-617.
42. Manna, P. P., and W. A. Frazier. 2003. The mechanism of CD47-dependent killing of T cells: heterotrimeric Gi-dependent inhibition of protein kinase A. J. Immunol. 170: 3544-3553.
43. Frazier, W. A., A. G. Gao, J. Dimitry, J. Chung, E. J. Brown, F. P. Lindberg, and M. E. Linder. 1999. The thrombospondin receptor integrin-associated protein (CD47) functionally couples to heterotrimeric Gi. J. Biol. Chem. 274: 8554-1560.
44. Gao, A. G., F. P. Lindberg, M. B. Finn, S. D. Blystone, E. J. Brown, and W. A. Frazier. 1996. Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin. J. Biol. Chem. 271: 21-24.
45. Carlson, C. B., D. A. Bernstein, D. S. Annis, T. M. Misenheimer, B. L. Hannah, D. F. Mosher, and J. L. Keck. 2005. Structure of the calcium-rich signature domain of human thrombospondin-2. Nat. Struct. Mol. Biol. 12: 910-914.
46. Isenberg, J. S., L. A. Ridnour, J. Dimitry, W. A. Frazier, D. A. Wink, and D. D. Roberts. 2006. CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1. J. Biol. Chem. 281: 26069-26080.
47. Kvansakul, M., J. C. Adams, and E. Hohenester. 2004. Structure of a thrombospondin C-terminal fragment reveals a novel calcium core in the type 3 repeats. EMBO J. 23: 1223-1233.
48. Pettersen, R. D. 2000. CD47 and death signaling in the immune system. Apoptosis 5: 299-306.
49. Bornstein, P., and E. H. Sage. 1994. Thrombospondins. Methods Enzymol. 245: 62-85.
50. Bornstein, P. 2001. Thrombospondins as matricellular modulators of cell function. J. Clin. Invest. 107: 929-934.
51. Bornstein, P., A. Agah, and T. R. Kyriakides. 2004. The role of thrombospondins 1 and 2 in the regulation of cell-matrix interactions, collagen fibril formation, and the response to injury. Int. J. Biochem. Cell Biol. 36: 1115-1125.
52. Li, Z., M. J. Calzada, J. M. Sipes, J. A. Cashel, H. C. Krutzsch, D. S. Annis, D. F. Mosher, and D. D. Roberts. 2002. Interactions of thrombospondins with α4β1 integrin and CD47 differentially modulate T cell behavior. J. Cell Biol. 157: 509-519.
53. Li, Z., L. He, K. Wilson, and D. Roberts. 2001. Thrombospondin-1 inhibits TCR-mediated T lymphocyte early activation. J. Immunol. 166: 2427-2436.
54. Doyen, V., M. Rubio, D. Braun, T. Nakajima, J. Abe, H. Saito, G. Delespesse, and M. Sarfati. 2003. Thrombospondin 1 is an autocrine negative regulator of human dendritic cell activation. J. Exp. Med. 198: 1277-1283.
55. Savill, J., I. Dransfield, C. Gregory, and C. Haslett. 2002. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol. 2: 965-975.
56. Yamao, T., T. Noguchi, O. Takeuchi, U. Nishiyama, H. Morita, T. Hagiwara, H. Akahori, T. Kato, K. Inagaki, H. Okazawa, et al. 2002. Negative regulation of platelet clearance and of the macrophage phagocytic response by the transmembrane glycoprotein SHPS-1. J. Biol. Chem. 277: 39833-39839.
57. Li, S. S., Z. Liu, M. Uzunel, and K. G. Sundqvist. 2006. Endogenous thrombospondin-1 is a cell surface ligand for regulation of integrin dependent T lymphocyte adhesion. Blood 9: 3112-3120.
58. + T cell-mediated cutaneous immune responses by restricting effector T cell development through a Fas ligand-dependent mechanism. J. Immunol. 172: 2286-2295.
59. + T cells in the immune response to the contact sensitizer trinitrophenyl. J. Immunol. 173: 3178-3185.
60. Kubasiak, L. A., O. M. Hernandez, N. H. Bishopric, and K. A. Webster. 2002. Hypoxia and acidosis activate cardiac myocyte death through the Bcl-2 family protein BNIP3. Proc. Natl. Acad. Sci. USA 99: 12825-12830.